SCHEMBL13005484

SCHEMBL13005484

CC(C)Cc1cccc(CN(C)[C@@H](Cc2ccccc2)CN(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 9/20 0.47
SLC6A2 P23975 3/20 0.47
SLC6A4 P31645 2/20 0.47
SLC6A3 Q01959 2/20 0.47
ADRA2B P18089 1/20 0.47
ADRA2C P18825 1/20 0.47
HTR2A P28223 1/20 0.47
ADRA1A P35348 1/20 0.47
KCNH2 Q12809 1/20 0.47
CETP P11597 1/20 0.41
OPRD1 P41143 8/20 0.40
SIGMAR1 Q99720 3/20 0.39
TAAR1 Q96RJ0 2/20 0.39
MAOA P21397 1/20 0.39
CYP2A6 P11509 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
MAOB P27338 1/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005495 0.87 OPRK1 (0.43) OPRK1SLC6A2SLC6A4SLC6A3ADRA2B
SCHEMBL13005487 0.86 CETP (0.40) OPRK1SLC6A2SLC6A4SLC6A3ADRA2B
SCHEMBL13005494 0.83 ALOX5 (0.41) CETPGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL13005492 0.82 TSHR (0.42) OPRK1SLC6A2SLC6A4SLC6A3ADRA2B
SCHEMBL13005518 0.81 CETP (0.40) OPRK1SLC6A2SLC6A4SLC6A3ADRA2B
SCHEMBL13005557 0.79 SIGMAR1 (0.41) OPRK1SLC6A2SLC6A4SLC6A3ADRA2B
SCHEMBL13005605 0.78 SLC6A2 (0.45) OPRK1SLC6A2SLC6A4SLC6A3ADRA2B
SCHEMBL13005597 0.78 ALDH1A1 (0.42) OPRK1SLC6A2SLC6A4SLC6A3ADRA2B
SCHEMBL22388384 0.78 ADRA2B (0.46) OPRK1SLC6A2SLC6A4SLC6A3ADRA2B
SCHEMBL16640979 0.78 ALDH1A1 (0.50) OPRK1SLC6A2SLC6A4SLC6A3ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed